Approvals/TGA/PRALUENT alirocumab 150mg/mL, solution for injection, pre-filled pen

Approved

STANDARD

PRALUENT alirocumab 150mg/mL, solution for injection, pre-filled pen

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 697d3fbfa2d6d067
Product Name: PRALUENT alirocumab 150mg/mL, solution for injection, pre-filled pen
Artg Id: 238299
Artg Name: PRALUENT alirocumab (rch) 150mg/mL solution for injection pre-filled pen
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2016-05-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/bb8f5d77deb5f86b1d6fe78f9dfedb79.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/83c34478681b549984b83717bde291e5.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

697d3fbfa2d6d067

Type

Standard